Nano building blocks via iodination of [PhSiO1.5]n, forming [p-I-C6H4SiO1.5]n (n = 8, 10, 12), and a new route to high-surface-area, thermally stable, microporous materials via thermal elimination of I2.

We describe the synthesis and characterization of the homologous p-iodophenylsilsesquioxanes (SQs) [p-I-C(6)H(4)SiO(1.5)](n) (n = 8, 10, 12) via ICl-promoted iodination (-40 to -60 degrees C) with overall yields of 80-90% and > 95% para selectivity following recrystallization. Characterization by NMR, FTIR, TGA, and single-crystal X-ray diffraction are reported and compared to data previously published for I(8)OPS. Coincidentally, we report a new synthesis of the elusive pentagonal decaphenyl SQ (dPS) [C(6)H(4)SiO(1.5)](10) and its characterization by NMR and single-crystal X-ray studies. These unique macromolecules possess equivalent chemical functionality but varying symmetries (cubic, pentagonal, and D(2d) dodecahedral), offering the potential to develop homologous series of functionalized star and dendrimer compounds with quite different core geometries and thereby providing the potential to greatly vary structure-property relationships in derivative compounds and nanocomposites made therefrom. We find that all three compounds decompose on heating to approximately 400 degrees C/N(2) with loss of I(2) to form robust, microporous materials with BET surface areas of 500-700 m(2)/g, pore volumes of 0.25-0.31 cm(3)/g, average pore widths of 8 A, and oxidative stabilities > or = 500 degrees C and with solid-phase morphologies varying from crystalline to mostly amorphous, as indicated by powder XRD and SEM studies. These latter findings point to important symmetry effects relating directly to packing in the crystalline phase prior to thermolysis.

Kinetics and mechanism of inhibition of serine esterases by fluorinated aminophosphonates.

This paper reviews previously published data and presents new results to address the hypothesis that fluorinated aminophosphonates (FAPs), (RO)(2)P(O)C(CF(3))(2)NHS(O)(2)C(6)H(5), R=alkyl, inhibit serine esterases by scission of the P-C bond. Kinetics studies demonstrated that FAPs are progressive irreversible inhibitors of acetylcholinesterase (AChE, EC 3.1.1.7.), butyrylcholinesterase (BChE, EC 3.1.1.8.), carboxylesterase (CaE, EC 3.1.1.1.), and neuropathy target esterase (NTE, EC 3.1.1.5.), consistent with P-C bond breakage. Chemical reactivity experiments showed that diMe-FAP and diEt-FAP react with water to yield the corresponding dialkylphosphates and (CF(3))(2)CHNHS(O)(2)C(6)H(5), indicating lability of the P-C bond. X-ray crystallography of diEt-FAP revealed an elongated (and therefore weaker) P-C bond (1.8797 (13)A) compared to P-C bonds in dialkylphosphonates lacking alpha-CF(3) groups (1.805-1.822A). Semi-empirical and non-empirical molecular modeling of diEt-FAP and (EtO)(2)P(O)C(CH(3))(2)NHS(O)(2)C(6)H(5) (diEt-AP), which lacks CF(3) groups, indicated lengthening and destabilization of the P-C bond in diEt-FAP compared to diEt-AP. Active site peptide adducts formed by reacting diEt-FAP with BChE and diBu-FAP with NTE catalytic domain (NEST) were identified using peptide mass mapping with mass spectrometry (MS). Mass shifts (mean+/-SE, average mass) for peaks corresponding to active site peptides with diethylphosphoryl and monoethylphosphoryl adducts on BChE were 136.1+/-0.1 and 108.0+/-0.1Da, respectively. Corresponding mass shifts for dibutylphosphoryl and monobutylphosphoryl adducts on NEST were 191.8+/-0.2 and 135.5+/-0.1Da, respectively. Each of these values was statistically identical to the theoretical mass shift for each dialkylphosphoryl and monoalkylphosphoryl species. The MS results demonstrate that inhibition of BChE and NEST by FAPs yields dialkylphosphoryl and monoalkylphosphoryl adducts, consistent with phosphorylation via P-C bond cleavage and aging by net dealkylation. Taken together, predictions from enzyme kinetics, chemical reactivity, X-ray crystallography, and molecular modeling were confirmed by MS and support the hypothesis that FAPs inhibit serine esterases via scission of the P-C bond.

Preparation of site-differentiated mixed ligand and mixed ligand/mixed metal metallacrowns.

Assembly reactions that can prepare reliably regioselective metallamacrocyclic complexes have been a target in the development of metallacrowns. To this end, a series of mixed ligand and mixed ligand/mixed metal metallacrowns have been synthesized in high yield and structurally characterized. Two distinct connectivities have been observed in these types of metallacrowns. The monomeric, vacant metallacrown with mixed ligand composition [12-MC(Ni(II)N(Hshi)2(pko)2-4)] (1a) shows the connectivity pattern [-O-Ni-O-N-Ni-N-]2 while the other Ni metallacrowns, [12-MC(Ni(II)N(shi)2(pko)2-4)] (2a) and the coupled [12-MC(Ni(II)N(shi))2(pko)2-4)][12-MC(Ni(II)N(shi))3(pko)-4)] (3a) fused metallacrowns as well as the mixed metal Mn-Ni metallacrown [12-MC(Ni(II)Mn(III)N(shi)2(pko)2-4)] (4a), follow the pattern [-Ni-O-N-]4. Also, three distinct arrangements of the chelate rings around the metal ions have been observed. The syntheses are completely general, allowing for the substitution of different ligands into the metallacrown core. Compounds 1 and 4 show the 6-5-6-5-6-5-6-5 arrangement, compounds 2 and 3(1) the 6-6-5-5-6-6-5-5, and the 3(2) component the 6-6-5-5-6-5-6-5. The obtained structures can be rationalized by balancing the charge at each metal site in the metallacrown. Variable temperature magnetic susceptibility measurements show that exchange interactions for all the compounds are weak and dominantly antiferromagnetic (e.g., 2a gives an exchange coupling of J = -1.2 cm(-1) with g = 2.2). In solution, the metallacrowns are shown to be stable both to decomposition and ligand exchange.

Molecular structures of carbonyl-linked bis(dioxolene) complexes: can a carbonyl group act as an effective ferromagnetic coupler?

Molecular structures of two bis(ZnIIdioxolene) complexes are described: (TpCum,MeZn)(2)1-H2 (C106H123.50B2N12O10Zn2), tetragonal, P4/ncc, a = 25.1810(2) A, b = 25.1810(2) A, c = 34.7744(2) A, alpha = 90 degrees, beta = 90 degrees, gamma = 90 degrees, Z = 8; (TpCum,MeZn)(2)1-H (C101H120B2N12O6Zn2), triclinic, P1, a = 13.6624(2) A, b = 13.80920(10) A, c = 26.62340(10) A, alpha = 96.6910(10) degrees, beta = 91.8560(10) degrees, gamma = 109.0190(10) degrees, Z = 2. One of the complexes, (TpCum,MeZn)(2)1-H2, has two protonated catecholate ligands, while the other complex, (TpCum,MeZn)(2)1-H, has one protonated catecholate and one semiquinone ligand. When reacted with PbO2, a labile S = 1, bis(ZnIIsemiquinone) complex is formed in which the two semiquinones are attached to a common carbonyl group.

Synthesis and structure of a complex having a quartet ground state with three entirely different spin carriers: nitronyl nitroxide, o-semiquinone, and CuII.

A "spin diverse" S = 3/2 ground-state complex, NN-SQCuTpCum,Me, has been prepared. The three S = 1/2 spin carriers are nitronyl nitroxide (NN), o-semiquinone (o-SQ), and cupric ion. The solid-state structure of the ZnII derivative, NN-SQZnTpCum,Me (C56H69BN8O4Zn), was determined: monoclinic, P2(1)/c, a = 12.5781(12) A, b = 17.7408(17) A, c = 24.440(2) A, alpha = 90.00 degrees, beta = 98.240(2) degrees, gamma = 90.00 degrees, Z = 4. The results of X-ray structural characterization of the ZnII derivative suggest substantial interaction between the two spin carriers NN and o-SQ. Indeed, strong intramolecular exchange coupling has been determined by variable-temperature magnetic susceptibility studies. Intraligand ferromagnetic exchange is considerably greater than kT, such that only the triplet state is populated at 300 K, and CuII-ligand exchange is ferromagnetic, with J = +75 cm-1.

N-Acetyl-L-phenylalanine.

The structure of the title compound, C(11)H(13)NO(3), is characterized by a two-dimensional infinite network of intermolecular N-H.O and O-H.O hydrogen bonds.

Active Role of a Germylene Ligand in Promoting Reactions of Platinum Complexes with Oxygen and Sulfur Dioxide.

The reaction of (Et(3)P)(2)PtGe[N(SiMe(3))(2)](2) with dioxygen yields (Et(3)P)(2)Pt(&mgr;-eta(2)-O(2))Ge[N(SiMe(3))(2)](2) (1). Exposure of 1 to light resulted in a rearrangement to (Et(3)P)(2)PtO(2)Ge[N(SiMe(3))(2)](2) (2a), the first example of a bidentate, dianionic germanate ligand. The isomerization was judged to occur via an intramolecular O-O bond scission and rotation of the Pt-Ge bond. No free germylene was detected, and the reaction was found to be zero order. An analogue of 2a was prepared by direct reaction of (Ph(3)P)(2)PtO(2) with Ge[N(SiMe(3))(2)](2) yielding (Ph(3)P)(2)PtO(2)Ge[N(SiMe(3))(2)](2) (2b). Addition of SO(2) to 1 results in the formation of the bridging sulfate (Et(3)P)(2)Pt(&mgr;-eta(2)-SO(4))Ge[N(SiMe(3))(2)](2) (3). An infrared spectroscopy study of the sulfate reaction was performed using oxygen-18. The results indicate that direct insertion of SO(2) into the O-O bond does not occur. Formaldehyde was also observed to insert into the Pt-O bond of 1 giving (Et(3)P)(2)Pt(&mgr;-eta(2)-OCH(2)OO)Ge[N(SiMe(3))(2)](2) (5).

Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.

The first two analogs 5a,b of a new class of neutral large-ring square-planar Pt(II) chelate complexes of the generic structure [Pt(cis-1,4-dach)X2] were synthesized via a refined technique, structurally characterized by NMR (1H, 13C, 195Pt), FAB mass spectrometry, and X-ray crystallography, and evaluated for antitumor activity in vitro and in vivo in sensitive and Pt-resistant murine leukemia cell systems. An X-ray crystal structure analysis confirmed that [Pt(cis-1,4-dach)malonate] 5b is monomeric and that the cis-1,4-diaminocyclohexane (dach) ligand is incorporated in a unique and previously unknown locked boat conformation. Complex 5b crystallized as colorless rectangular plates in the orthorhombic space group Pcmn with Z = 4 and the lattice parameters a = 6.239(1) A, b = 9.965(2) A, and c = 18.437(4) A. Important structural parameters are Pt-O = 2.024(5) A, Pt-N = 2.021(6) A, N-Pt-N = 100 degrees, and N-Pt-O = 85 degrees; R = 0.0515, Rw = 0.0635. Antitumor results in murine tumor models show that the parent molecule 5a (X2 = 2 Cl) (a) is more dose potent than cisplatin against the leukemias and solid tumors examined, (b) possesses significant activity against cisplatin-resistant leukemias, but exhibits partial cross-resistance with cisplatin, and (c) may possess a spectrum of activity different from that of cisplatin. Antitumor test results in vitro indicate that (a) 5a is at least equivalent to cisplatin in dose potency and effectiveness in the leukemia cell systems studied except in the [Pt(1,2-dach)Cl2]-resistant L1210 cell line, (b) the cisplatin-resistant leukemia cell systems exhibit partial cross-resistance to 5a, (c) 5a possesses either comparable or greater cytotoxicity than the reference complexes, CI-973 (3) and bis(platinum) complex 4, and (d) 5a is more effective (approximately 18-fold) than [Pt(1R,2R-dach)Cl2] 2 in inhibiting growth in the Pt(1,2-dach)-resistant L1210 cell line, suggesting that [Pt(cis-1,4-dach)Cl2] is either not recognized as or is not acting as a "typical" Pt(dach) complex. The encouraging antitumor activity of 5a, coupled with a 10-fold higher aqueous solubility compared to [Pt(1R,2R-dach)-Cl2] 2 warrants the following future studies: synthesis of selected analogs, elucidating the nature of Pt-DNA binding sites, the mechanism of action, and the mechanistic basis for the lack of cross-resistance of [Pt(cis-1,4-dach)Cl2] against the [Pt(1,2-dach)Cl2]-resistant L1210 cell line.